Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biocryst Pharmaceuticals

8.76
-0.1200-1.35%
Post-market: 8.800.0400+0.46%17:36 EDT
Volume:2.42M
Turnover:21.15M
Market Cap:1.83B
PE:-33.76
High:8.87
Open:8.87
Low:8.69
Close:8.88
Loading ...

Earnings Flash (BCRX) BioCryst Pharmaceuticals Posts Q1 EPS $0.00, vs. FactSet Est of $0.07 Loss

MT Newswires Live
·
05 May

BRIEF-BioCryst Pharmaceuticals Q1 EPS USD 0 Vs. IBES Estimate USD -0.07

Reuters
·
05 May

BioCryst Pharmaceuticals Inc: FY 2025 Orladeyo Revenue Guidance Increased to $580 Mln to $600 Mln

THOMSON REUTERS
·
05 May

BioCryst Pharmaceuticals Inc: Expects to Be Profitable for Full Year 2025, a Year Ahead of Schedule

THOMSON REUTERS
·
05 May

BioCryst Pharmaceuticals Q1 EPS USD 0 VS. Ibes Estimate USD -0.07

THOMSON REUTERS
·
05 May

BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
05 May

North American Morning Briefing: Stock Futures Down As Oil Plunges

Dow Jones
·
05 May

High Growth Tech Stocks To Watch In The US May 2025

Simply Wall St.
·
03 May

BRIEF-Biocryst Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
02 May

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
02 May

BioCryst Appoints Steve Frank to Board of Directors

THOMSON REUTERS
·
01 May

Press Release: BioCryst Appoints Steve Frank to Board of Directors

Dow Jones
·
01 May

Inotiv, Inc. (NOTV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
30 Apr

BioCryst to Present at Upcoming Investor Conferences

GlobeNewswire
·
30 Apr

BioCryst Pharmaceuticals Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
29 Apr

BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks
·
28 Apr

BioCryst to Report First Quarter 2025 Financial Results on May 5

GlobeNewswire
·
21 Apr

Bank of America Securities Keeps Their Buy Rating on BioCryst (BCRX)

TIPRANKS
·
17 Apr

BioCryst Pharmaceuticals Price Target Maintained With a $11.00/Share by RBC Capital

Dow Jones
·
11 Apr

How BioCryst Pharmaceuticals, Inc. (BCRX) Stock Stands Out in a Strong Industry

Zacks
·
11 Apr